Frankfurt - Delayed Quote EUR

Relevium Technologies Inc. (6BX.F)

0.0075 0.0000 (0.00%)
As of January 10 at 8:17 AM GMT+1. Market Open.
Loading Chart for 6BX.F
DELL
  • Previous Close 0.0075
  • Open 0.0075
  • Bid --
  • Ask --
  • Day's Range 0.0075 - 0.0075
  • 52 Week Range 0.0075 - 0.0075
  • Volume 10,000
  • Avg. Volume 0
  • Market Cap (intraday) 4.889M
  • Beta (5Y Monthly) 1.96
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.

www.releviumtechnologies.com

--

Full Time Employees

June 30

Fiscal Year Ends

--

Sector

--

Industry

Related News

Performance Overview: 6BX.F

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

6BX.F
0.00%
S&P/TSX Composite index
4.37%

1-Year Return

6BX.F
0.00%
S&P/TSX Composite index
5.70%

3-Year Return

6BX.F
40.00%
S&P/TSX Composite index
14.51%

5-Year Return

6BX.F
85.00%
S&P/TSX Composite index
31.22%

Compare To: 6BX.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6BX.F

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.50%

  • Return on Assets (ttm)

    4.20%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    14.25M

  • Net Income Avi to Common (ttm)

    -2.64M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    697.39k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -585.43k

Company Insights: 6BX.F